Innocoll Holdings plc
Period: Nov 3, 2016 to Dec 29, 2016
Lead Plaintiff Deadline: Mar 27, 2017
Summary of Case:
A securities class action has been filed against Innocoll Holdings plc securities (NASDAQ:INNL) on behalf of purchasers of Innocoll securities between November 3, 2016 through December 29, 2016. This case has been filed in the USDC - Eastern District of Pennsylvania.
The Complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Innocoll's New Drug Application ("NDA") submission to the FDA in October 2016 for XARACOLL was incomplete; (2) due to the incomplete NDA submission, XARACOLL would not be approved in 2017 as investors were led to believe; and (3) as a result, Defendants' statements about Innocoll's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.